Charles River Discovery Research Services Germany GmbH

Tweet this page
<
2012
2013
2014
2015
2016
2017
>
No longer registered as of 13 Feb 2018 - Registration as it was on 11 Feb 2017
How to read and use this data card.
Download this datacard

Overview

Lobbying Costs

9,999€

Financial year: Jan 2016 - Dec 2016

Lobbyists (Full time equivalent)

1 Fte (2)

Lobbyists with EP accreditation

0

High-level Commission meetings

0

Lobbying Costs over the years

  • Info

    Charles River Discovery Research Services Germany GmbH   (Charles River FBG)

    EU Transparency Register

    52102399616-04 First registered on 13 Sep 2012

    Goals / Remit

    Oncotest is a Contract Research Organization offering preclinical efficacy profiling of novel anti-cancer molecules. Promising indications and potential biomarkers are identified using a combination of in vitro and in vivo technologies with Oncotest’s extensively characterized collection of more than 350 unique patient-derived tumor xenografts (PDX) growing in nude mice.

    Main EU files targeted

    IMI inititative

    Address

    Head Office
    Am Flughafen, 12-14
    Freiburg 79108
    GERMANY
  • People

    Total lobbyists declared

    2

    Employment timeLobbyists
    50%2

    Lobbyists (Full time equivalent)

    1

    Lobbyists with EP accreditation

    No lobbyists with EP accreditations

    Complementary Information

    None declared

    Person in charge of EU relations

    Ms Sabine Gorynia (CEO)

    Person with legal responsibility

    Ms Sabine Gorynia (CEO)

  • Categories

    Category

    II - In-house lobbyists and trade/business/professional associations

    Subcategory

    Companies & groups

  • Networking

    Affiliation

    Bio Deutschland

    Member organisations

    None declared

  • Financial Data

    Closed financial year

    Jan 2016 - Dec 2016

    Lobbying costs for closed financial year

    9,999€

    Other financial info

    None declared

  • EU Structures

    Groups (European Commission)

    None

    ACC

    None

    Groups (European Parliament)

    None

    Communication activities

    None

    Other activities

    Innovative Medicines Initiative

  • Meetings

    Meetings

    None declared

Download this datacard